Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CHAMPION-AF Clinical Trial

NCT: NCT04394546 · ACTIVE_NOT_RECRUITING

NCT IDNCT04394546
StatusACTIVE_NOT_RECRUITING
Start Date2020-10-15
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of this study is to determine if left atrial appendage closure (LAAC) with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑